How to Sell Peptides Without Getting Your Accounts Banned

Nearly every peptide brand shutdown we have seen traces back to the same root cause: the ad said one thing, the landing page said another, the product labeling said a third, and the merchant application said a fourth. Platforms and acquirers are not trying to catch you being clever. They are checking whether your story is consistent, and inconsistency is what gets flagged.

This article is about doing it the right way so you stay live. It is not about evading review. If your business only works when a reviewer does not look closely, you do not have a business, you have a countdown.

reason 1: your ad copy uses personal attributes

Meta prohibits ads that assert or imply knowledge of a person's health status, body, or personal characteristics. This is the most common rejection in the category and it is usually accidental. The pattern to avoid is second-person framing about the viewer's body or condition.

• —Rejected pattern: addressing the viewer as though you know their weight, health condition, or physical struggle.
• —Rejected pattern: rhetorical questions that presume a condition, then position the product as the fix.
• —Rejected pattern: before-and-after imagery, scale imagery, or body-part close-ups used as transformation proof.
• —Rejected pattern: specific outcome promises with numbers or timelines.
• —Compliant alternative: describe the program, the process, the standards, and who it is for in the third person, and let the viewer self-select.

This constraint feels punitive until you run it and discover educational and credibility-led creative frequently outperforms the aggressive stuff anyway. On AC-NEXTGEN, top creatives inside these constraints ran 7.5 to 16 ROAS. On LIVV Well, 6.79 to 14.96.

reason 2: your landing page contradicts your model

Reviewers look at the destination, not just the ad. If you sell research-use-only product and your landing page has dosing protocols, injection guidance, or testimonials describing personal results, your RUO framing is not credible and neither your ad account nor your merchant account will survive scrutiny.

1. 1.Make the page match the lane. RUO pages carry clear not-for-human-consumption labeling, no dosing content, and no human-use testimonials. Clinical pages route to a real intake with a real provider review.
2. 2.Make the page match the ad. If the ad talks about lab testing standards, the page should lead with lab testing standards. Mismatch is the top trigger for manual review.
3. 3.Keep disclaimers visible and consistent, not buried in a footer nobody reads. A disclaimer that contradicts the rest of your page protects nobody.
4. 4.Remove borrowed credibility. No implied endorsements, no logos of publications that never covered you, no invented clinical affiliations.
5. 5.Publish real proof instead: independent lot COAs, your provider's license and credentials, your fulfillment standards.

reason 3: your merchant account is miscoded

Applying for a standard merchant account and describing your business as supplements or wellness products when you sell peptides is the fastest route to a frozen balance. When the freeze comes, it typically holds funds for 90 to 180 days, and a termination for misrepresentation can land you on the MATCH list, which makes the next merchant account substantially harder to obtain.

Do it the other way. Apply to a high-risk acquirer, describe exactly what you sell, provide your COAs and policies, and accept the higher rate and the rolling reserve. You will pay 3.5 to 5.5 percent instead of 2.9, and you will still be processing in year two.

account structure that limits blast radius

Even compliant advertisers get caught in automated enforcement occasionally. The goal is that a single false positive does not take down the company.

• —Verify your domain in Business Manager and keep domain, business entity, and merchant application aligned on the same legal name.
• —Use a properly aged business manager with a clean history rather than a brand new asset pushing large spend on day one.
• —Two approved payment processors, always. Redundancy is the single highest-value insurance in this business.
• —Separate ad accounts by function where it makes sense, so a restriction on one does not immediately halt all spend.
• —Keep your appeals professional and factual. Vague appeals rarely succeed; appeals that cite the specific policy and explain the compliant reading often do.
• —Never buy or rent accounts. It voids any legitimate appeal path and violates platform terms outright.

chargebacks: the quiet account killer

Card networks run monitoring programs that start biting around the 0.9 to 1 percent mark. Exceeding thresholds means fines, mandatory remediation, and eventually termination. In this category, most chargebacks are not fraud, they are confusion.

1. 1.Use a billing descriptor that matches the brand name the customer bought from, plus a phone number.
2. 2.Send an immediate order confirmation and a shipping notification with tracking. Silence produces disputes.
3. 3.Answer support within one business day, with a human. Most disputes are preventable with a reply.
4. 4.Refund quickly when it is close. A $60 refund is cheaper than a $60 chargeback plus a $35 fee plus a ratio hit.
5. 5.For subscriptions, make cancellation obvious and one-click. Hard-to-cancel programs generate disputes at several times the normal rate.
6. 6.Deploy chargeback alerts so you can refund before a dispute is formally filed.

the compliance habits of brands that stay live

• —A single source-of-truth claims document that legal has approved, which creative, email, and support all work from.
• —Legal re-review whenever a SKU, claim, or lane changes. Not annually, on change.
• —Creative review before launch, not after rejection. Rejections accumulate against the account.
• —Published lot COAs from an independent lab, kept current. This is both a trust asset and a compliance asset.
• —Age gating and buyer attestation on RUO stores, enforced at checkout.
• —No affiliate or influencer content that makes claims you would not make yourself. You are responsible for what your affiliates say.

That last point catches people. An affiliate posting dosing protocols or transformation claims about your product creates exposure for you. Give affiliates an approved claims sheet and enforce it.

the goal is not to survive review. the goal is to build something where review is boring.

Nothing here is legal advice, and none of it is a method for circumventing platform enforcement. If your model requires hiding what you sell from your processor or your ad platform, the correct fix is the model, not the disclosure. Retain a healthcare regulatory attorney and build something that holds up when someone looks.